Attenzione! Per visualizzare al meglio il sito e usufruire di tutte le funzionalità messe a disposizione
si consiglia di aggiornare la versione in uso di Internet Explorer alla versione 8 o superiore. Grazie!

Con il passaggio alla nuova versione
del sito e ad un diverso provider tecnologico, non è più possibile
utilizzare la vecchia utenza/password
di SIN-ITALY.

Coloro che sono registrati su nephroMEET possono accedere a questo nuovo sito utilizzando la stessa utenza e password di nephroMEET.

Se non sei registrato a nephroMEET, ma eri registrato sul sito
SIN-ITALY, clicca qui

Inserisci il tuo codice fiscale e la mail per recuperare i tuoi dati anagrafici ed effettuare il passaggio al nuovo sito:



Abbiamo inviato una e-mail all'indirizzo che ci hai indicato. Accedi alla tua casella di posta e segui le istruzioni inserite nella e-mail per completare il passaggio.

Vol. 2 — March-April 2011

  • Emerging strategies to preserve renal function

    Hélène Francois1, Antoine Jacquet1, Séverine Beaudreuil1, Alexandre Seidowsky1, Hadia Hebibi1, Bernard Charpentier1, Antoine Durrbach1

    (1) Department of Nephrology, Dialysis and Transplantation, Bicêtre Hospital, APHP, Paris - France and University of Paris XI Sud, Le Kremlin-Bicêtre - France

  • Calciphylaxis: a still unmet challenge

    Vincent M. Brandenburg1, Mario Cozzolino2, Markus Ketteler3

    (1) Department of Cardiology, University Hospital Aachen, Aachen - Germany
    (2) Renal Division, S. Paolo Hospital, University of Milan, Milan - Italy
    (3) Department of Nephrology, Klinikum Coburg, Coburg - Germany

  • The health system in Chile: the nephrologist perspective

    Leopoldo G. Ardiles1, Hugo Poblete2, Mireya Ortiz3, Susana Elgueta4, Ana María Cusumano5, Antonio Vukusich6, Sergio Mezzano7

    (1) Ardiles et al: Health Renal System in Chile
    (2) Department of Nephrology, Universidad de Valparaíso, Valparaíso - Chile
    (3) Department of Nephrology, Pontificia Universidad Católica de Chile, Santiago - Chile
    (4) Seccion de Histocompatibilidad, Subdepartamento de Inmunología, Instituto de Salud Pública de Chile, Santiago - Chile
    (5) Dialysis and Transplantation Registry Committee, Latin American Society of Nephrology and Hypertension (SLANH) - Buenos Aires, Argentina
    (6) Clínica Dávila, Universidad de Los Andes, Santiago - Chile
    (7) Department of Nephrology, Universidad Austral de Chile, Valdivia - Chile

  • Genomic and proteomic approaches to renal cell carcinoma

    Miriam Zacchia1, Annalisa Vilasi2, Anna Capasso2, Franco Morelli2, Ferdinando De Vita1, Giovambattista Capasso2

    (1) Nephrology and Oncology Division, Department of Internal Medicine, Second University of Naples, Naples – Italy
    (2) Nephrology and Oncology Division, Department of Internal Medicine, Second University of Naples, Naples - Italy

  • Renal replacement therapy in intensive care units: a survey of nephrological practice in northwest Italy

    Filippo Mariano1, Marco Pozzato2, Giorgio Canepari3, Corrado Vitale4, Francesca Bermond5, Colombano Sacco6, Alessandro Amore7, Massimo Manes8, Carlo Navino9, Piedmont and Aosta Valley Section of Italian Society of Nephrology10

    (1) Nephrology and Dialysis Unit, CTO Hospital, Turin - Italy
    (2) Nephrology and Dialysis Unit, Giovanni Bosco Hospital, Turin - Italy
    (3) Nephrology and Dialysis Unit, Santa Croce e Carle Hospital, Cuneo - Italy
    (4) Nephrology and Dialysis Unit, Mauriziano Hospital, Turin - Italy
    (5) Nephrology, Dialysis and Transplantation Unit, Molinettte Hospital and Nephrology and Dialysis Unit, Civile Hospital, Chivasso, Turin - Italy
    (6) Nephrology and Dialysis Unit, S.S. Antonio e Biagio Hospital, Alessandria - Italy
    (7) Nephrology, Dialysis and Transplantation Unit, OIRM Hospital, Turin - Italy
    (8) Nephrology and Dialysis Unit, Umberto Parini Hospital, Aosta - Italy
    (9) Nephrology and Dialysis Unit, Maggiore Hospital, Novara - Italy
    (10) Collaborators: Andrea Campo (Alba, CN), Dario Sassone (Asti), Gianmario Bosticardo (Biella), Paola Carpani (Borgomanero, NO), Giovanni Calabrese (Casale Monferrato, AL), Marco Formica (Ceva, CN), Emanuele Stramignoni (Chieri, TO), Alfonso Pacitti (Chivasso, TO), Andrea Serra (Cirie’, TO), Franco Bonello (Ivrea, TO), Antonio Marciello (Pinerolo, TO), Vincenzo Todini (Rivoli, TO), Carmelina di Tullio (Torino), Cesare Guarena (Torino), Maurizio Borzumati (Verbania), Gianenrico Guida (Vercelli)

  • Visfatin is related to lipid dysregulation, endothelial dysfunction and atherosclerosis in patients with chronic kidney

    Jiao Mu1, Bing Feng1, Zilin Ye1, Fahuan Yuan1, Wei Zeng1, Zhifeng Luo1, Wei Qi1

    (1) Institute of Nephrology of Chongqing and Department of Nephrology, Xinqiao Hospital, The Third Military Medical University, Chongqing - PR China

  • Increment of monthly mean predialysis heart rate reflects early cardiac overload in hemodialysis patients with normal ca

    Yuri Tanaka1, Nobuhiko Joki1, Masaki Iwasaki1, Igor G. Nikolov2, Yasunori Takahashi3, Chie Shiraki3, Takao Uchida4, Yoshihiko Imamura3, Hiroki Hase1

    (1) Division of Nephrology, Toho University Ohashi Medical Center, Tokyo - Japan
    (2) University Clinic of Nephrology, Medical Faculty, Skopje - Republic of Macedonia
    (3) Division of Dialysis Center, Nissan Tamagawa Hospital, Tokyo - Japan
    (4) Mitsui Clinic, Yamanashi - Japan

  • The myth of incompatibility of gentamicin and heparin revisited

    Bahar Bastani1

    (1) Division of Nephrology, Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, Missouri - USA

  • Design and patient characteristics of ESHOL study, a Catalonian prospective randomized study

    Francisco Maduell1, Francesc Moreso2, Mercedes Pons3, Rosa Ramos4, Josep Mora-Macià5, Andreu Foraster6, Jordi Soler7, Josep M. Galceran8, Alberto Martinez-Castelao9

    (1) Department of Nephrology, Hospital Clínic, Barcelona - Spain
    (2) Department of Nephrology, Hospital Universitari Vall d’Hebron, Barcelona - Spain
    (3) CETIRSA, Barcelona - Spain
    (4) Department of Nephrology, Hospital San Antonio Abad, Vilanova i la Geltru - Spain
    (5) Fresenius Medical Care, Granollers - Spain
    (6) Diaverum Baix Llobregat, Hospitalet - Spain
    (7) Fresenius Medical Care, Reus - Spain
    (8) Fundació Althaia, Manresa - Spain
    (9) Department of Nephrology, Hospital Universitari Bellvitge, Barcelona - Spain

  • Mycophenolate mofetil in treatment of childhood steroid-resistant nephrotic syndrome

    Tahar T.G. Gargah1, Mohamed Rachid Lakhoua1

    (1) Department of Pediatric Nephrology, Charles Nicolle Hospital, Tunis - Tunisia

  • A pilot study of routine colloid infusion in hypotension-prone dialysis patients unresponsive to preventive measures

    Guy Rostoker1, Mireille Griuncelli1, Christelle Loridon1, Thomas Bourlet2, Eric Illouz3, Abbes Benmaadi2

    (1) Division of Nephrology and Dialysis, Centre Hospitalier Privé Claude Galien, Quincy Sous Senart - France and Clinical Investigation laboratory, Centre Hospitalier Privé Claude Galien, Quincy Sous Senart - France
    (2) Division of Nephrology and Dialysis, Centre Hospitalier Privé Claude Galien, Quincy Sous Senart - France
    (3) Division of Cardiology, Centre Hospitalier Privé Claude Galien, Quincy Sous Senart - France

  • Possible involvement of intracellular angiotensin II receptor in high-glucose-induced damage in renal proximal tubular c

    Toshihiro Takao1, Taro Horino2, Toru Kagawa2, Reiko Matsumoto2, Yoshiko Shimamura2, Koji Ogata2, Kousuke Inoue2, Yoshinori Taniguchi2, Takafumi Taguchi2, Tatsuhito Morita2, Yoshio Terada2

    (1) Division of Community Medicine, Department of Community Nursing, Kochi Medical School, ?Nankoku - Japan
    (2) Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Nankoku - Japan

  • Management of secondary hyperparathyroidism in Italy: results of the Italian FARO survey

    Sandro Mazzaferro1, Diego Brancaccio2, Piergiorgio Messa3, Vittorio E. Andreucci4, Guido Bellinghieri5, Roberto Bigazzi6, Piergiorgio Bolasco7, Anna Maria Costanzo8, Umberto di Luzio Paparatti8, Giuseppe Cannella9, on behalf of the FARO Study Group

    (1) Clinical Science, Sapienza University, Rome - Italy
    (2) Department of Nephrology, San Paolo Hospital, Milan - Italy
    (3) Department of Nephrology, Policlinico Hospital, Milan - Italy
    (4) Department of Nephrology, University Federico II, Naples - Italy
    (5) Department of Nephrology, G. Martino Hospital, Messina - Italy
    (6) Department of Nephrology, Spedali Riuniti, Livorno - Italy
    (7) Department of Nephrology, U.O. Territoriale ASL8, Quartu S. Elena - Italy
    (8) Abbott Italy, Campoverde, Latina - Italy
    (9) Department of Nephrology, San Martino Hospital, Genoa - Italy

  • Improvement of hypertension and LVH in maintenance hemodialysis patients treated with sustained-release isosorbide monon

    Han Li1, Shi-xiang Wang1

    (1) Blood Purification Center, Beijing Chao-Yang Hospital, Capital Medical University, Beijing - PR China

  • Marked improvement by high-dose chemotherapy and autologous stem cell transplantation in a case of light chain depositio

    Keiichi Matsuzaki1, Isao Ohsawa1, Tomohito Nishitani1, Yukihiko Takeda1, Hiroyuki Inoshita1, Masaya Ishii1, Miyuki Takagi1, Satoshi Horikoshi1, Yasuhiko Tomino1

    (1) Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Tokyo - Japan

  • Risk for chronic kidney disease in high school students: Italian report for World Kidney Day 2008-2009

    D Russo, M Del Prete, Y Battaglia, L Russo

Per supporto ed assistenza:
Segreteria Società Italiana di Nefrologia
Tel. 06.4465270 – nefrologia@sin-italy.org

© 2014-2024 Società Italiana di Nefrologia. Tutti i diritti riservati.
Realizzazione: TESISQUARE®
Cookie Policy

Per accedere ai contenuti occorre essere registrati ed avere effettuato la login.
Se non lo sei ancora, puoi registrarti a partire da questo link.

×